Skip to content
OpenCapital
Get started

Bausch Health Companies BHC Cash & Equivalents

Cash & Equivalents at other companies

PBH
Prestige Consumer HealthcarePBH
$63.87M-34.8%
Bausch + Lomb logo
Bausch + LombBLCO
$279M+29.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$21.69B-43.6%
AbbVie logo
AbbVieABBV
$9.39B+81.5%
Organon logo
OrganonOGN
$1.12B+104%
HRO
HarrowHROW
$94.64M+41.8%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's cash & equivalents?
Bausch Health Companies (BHC) reported cash & equivalents of $1.31B in Q1 2026.
How has Bausch Health Companies's cash & equivalents changed year-over-year?
Bausch Health Companies's cash & equivalents increased by 13.4% year-over-year, from $1.16B to $1.31B.
What is the long-term trend for Bausch Health Companies's cash & equivalents?
Over 5 years (2020 to 2025), Bausch Health Companies's cash & equivalents has grown at a 17.0% compound annual growth rate (CAGR), from $605M to $1.33B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.